Machine Learning-Aided Intelligent Monitoring of Multivariate miRNA Biomarkers Using Bipolar Self-powered Sensors
ACS Nano · 11.03.2025 · 19 (9) · 8812-8825
DOI: 10.1021/acsnano.4c16423 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 26.02.2025. Verfasst von Jing Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China. Hauptthemen laut MEDLINE: MicroRNAs, Machine Learning, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Natural Science Basic Research Program of Shaanxi Province, Foundation of Henan Educational Committee.
Abstract (Originalsprache)
Breast cancer has become the most prevalent form of cancer among women on a global scale. The early and timely diagnosis of breast cancer is of the utmost importance for improving the survival rate of patients with this disease. The occurrence of breast cancer is typically accompanied by the dysregulation of multiple microRNA (miRNA) expression profiles. Consequently, simultaneous detection of multiple miRNAs is vital for the early and accurate diagnosis of breast cancer. In this study, a bipolar self-powered sensor was developed for the simultaneous detection of miRNA-451 and miRNA-145 breast cancer biomarkers based on the specific catalytic properties of enzymes. Selenides with a microporous hollow cubic structure were designed and prepared, which can markedly enhance the enzyme load and activity, as well as detection sensitivity, due to their extensive surface area and three-dimensional porous channel. The designed bipolar self-powered sensor platform is integrated into the commercial chip, and the signal is presented in the smartphone interface, thereby enabling real-time and continuous monitoring. Furthermore, machine learning was utilized to predict miRNA detection, which encompasses numerous stages, including data collection, feature extraction, model training, and validation. In comparison to the limited sensing efficiency of self-powered biosensors driven by enzyme biofuel cells, our bipolar self-powered sensor achieved simultaneous quantitative analysis of multiple miRNA targets, thereby providing a robust tool for a more comprehensive understanding of miRNA function and its association with cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
- College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang 464000, China.
- Institute of Medical Engineering, Department of Biophysics, School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an 710061, China.
ORCID-Profile: Fu Wang
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Natural Science Basic Research Program of Shaanxi Province
- Foundation of Henan Educational Committee
- Xinyang Normal University
- National Natural Science Foundation of China
- Henan University
Zitieren
APA
Xu, J., Luo, X., Chen, H., Guo, B., Wang, Z., & Wang, F. (2025). Machine Learning-Aided Intelligent Monitoring of Multivariate miRNA Biomarkers Using Bipolar Self-powered Sensors. ACS Nano, 19(9), 8812-8825. https://doi.org/10.1021/acsnano.4c16423
Vancouver
Xu J, Luo X, Chen H, Guo B, Wang Z, Wang F. Machine Learning-Aided Intelligent Monitoring of Multivariate miRNA Biomarkers Using Bipolar Self-powered Sensors. ACS Nano. 2025;19(9):8812-8825. doi:10.1021/acsnano.4c16423
BibTeX
@article{Xu2025,
author = {Xu, Jing and Luo, Xinqi and Chen, Hanxiao and Guo, Bin and Wang, Zhenlong and Wang, Fu},
title = {Machine Learning-Aided Intelligent Monitoring of Multivariate miRNA Biomarkers Using Bipolar Self-powered Sensors},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {9},
pages = {8812--8825},
doi = {10.1021/acsnano.4c16423}
}
EUVIMED